Ing Investment Management »

Alpine Immune Sciences shares owned by Ing Investment Management

Quarter-by-quarter ownership of Alpine Immune Sciences (ALPN) shares owned by Ing Investment Management from 13F filings

Historical chart of Ing Investment Management investment in Alpine Immune Sciences

Tip: Access up to 7 years of quarterly data

All positions including Alpine Immune Sciences held by Ing Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Alpine Immune Sciences by Ing Investment Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $851k 22k 39.64
2023-09-30 $155k 14k 11.45
2023-06-30 $135k 13k 10.28

More positions owned by Ing Investment Management

Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Apple (AAPL)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl A (GOOGL)
Wisdomtree Tr Voya Yld Enhncd (UNIY)
Broadcom (AVGO)
Tesla Motors (TSLA)
salesforce (CRM)
Eli Lilly & Co. (LLY)
Bank of America Corporation (BAC)
Datadog Cl A Com (DDOG)
Mastercard Incorporated Cl A (MA)
Home Depot (HD)

View all positions for Ing Investment Management

Top funds holding Alpine Immune Sciences

Decheng Capital
venBio Select Advisor
BlackRock
Frazier Life Sciences Management
T. Rowe Price Associates
State Street Corporation
Vanguard Group
Cormorant Asset Management
OrbiMed Advisors
Lynx1 Capital Management
Paradigm Biocapital Advisors
Darwin Global Management
Commodore Capital
Octagon Capital Advisors
Avidity Partners Management

View all funds holding Alpine Immune Sciences